Dynamics of Interaction Between Erythrocytes and Vascular Endothelium Under IFN-Alpha: An Optical Tweezers Study
Open Access
- 20 October 2026
- journal article
- Published by IMR Press in International Journal of Pharmacology
- Vol. 22 (6)
Abstract
Background: Interferon alpha (IFN-α) is an antiviral drug with widespread clinical use. Several studies report its effects on the endothelium, including the regulation of nitric oxide (NO) production. Such effects may cause adverse effects in patients with altered blood microrheology, as the interaction between red blood cells (RBCs) and the endothelium is a key factor governing blood microrheology. This study aimed to investigate the effect of IFN-α on the RBC–endothelium system in vitro. Methods: Human umbilical vein endothelial cells (HUVECs) were used as a model of vascular endothelium; human RBCs were obtained from healthy donors, and the forces of intercellular interactions were measured using optical tweezers. Statistical significance was assessed using the Mann–Whitney U test. Results: In the short-term exposure (15–60 minutes), the addition of IFN-α decreased RBC aggregation forces indirectly via the activation of the capacity of HUVECs to produce signaling molecules. Long-term (24 hours) HUVEC incubation with IFN-α had almost no effect, and long-term IFN-α incubation followed by short-term IFN-α reintroduction resulted in a weaker effect at higher concentrations. In the latter case, RBC–HUVEC adhesion decreased at certain concentrations. The minimal sample size comprised five measurements for each of the three donors at each IFN-α concentration. Conclusions: These findings reveal a complex interplay between interferon, endothelium, and RBCs, which should be considered in certain clinical applications of IFN-α. In particular, short-term endothelial exposure to IFN-α can decrease RBC aggregation, which may be helpful or harmful depending on the clinical condition of the patients. Long-term IFN-α treatment followed by short-term IFN-α exposure can decrease RBC–endothelium adhesion forces, altering blood microrheology.Keywords
Funding Information
- Theoretical Physics and Mathematics Advancement Foundation “BASIS” (23-2-2-34-1)
This publication has 52 references indexed in Scilit:
- Toxicity and efficacy of type I interferons on the ocular surface: in vitro, animal, and clinical studiesThe Ocular Surface, 2024
- Nitric oxide bioavailability for red blood cell deformability in the microcirculation: A review of recent progressNitric Oxide, 2022
- Interferon induced thrombotic microangiopathy (TMA): Analysis and concise reviewCritical Reviews in Oncology/Hematology, 2017
- Heme changes HIF-α, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapiesMicrovascular Research, 2016
- Nitric oxide secretion by endothelial cells in response to fluid shear stress, aspirin, and temperatureJournal of Biomedical Materials Research Part A, 2014
- RBC NOS: regulatory mechanisms and therapeutic aspectsTrends in Molecular Medicine, 2008
- Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2bInternational Journal of Pharmaceutics, 2007
- Side Effects of Interferon-α TherapyPharmacy World & Science, 2005
- Interferon-α 2b Enhances Barrier Function of Bovine Retinal Microvascular Endothelium in VitroMicrovascular Research, 1995
- Interferon alpha-2b in the long-term treatment of essential thrombocythemiaAnnals of Hematology, 1991